Skip to main content

Weaning from Extracorporeal Circulatory Support

  • Chapter
  • First Online:
ECMO-Extracorporeal Life Support in Adults

Abstract

Extracorporeal membrane oxygenation provides effective circulatory support while waiting for cardiac recovery in patients with potentially reversible heart disease, or for heart transplantation, or for implantation of a ventricular assist device (VAD) in patients with terminal heart disease [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N (2006) Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant 25(5):504–509

    Article  PubMed  Google Scholar 

  2. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Pavie A, Chastre J (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36(5):1404–1411

    Article  PubMed  Google Scholar 

  3. Bakhtiary F, Keller H, Dogan S, Dzemali O, Oezaslan F, Meininger D, Ackermann H, Zwissler B, Kleine P, Moritz A (2008) Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 135(2):382–388

    Article  PubMed  Google Scholar 

  4. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM 3rd (2001) Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 122(1):92–102

    Article  CAS  PubMed  Google Scholar 

  5. Unosawa S, Sezai A, Hata M, Nakata K, Yoshitake I, Wakui S, Kimura H, Takahashi K, Hata H, Shiono M (2013) Long-term outcomes of patients undergoing extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. Surg Today 43(3):264–270

    Article  PubMed  Google Scholar 

  6. Slottosch I, Liakopoulos O, Kuhn E, Deppe AC, Scherner M, Madershahian N, Choi YH, Wahlers T (2013) Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. J Surg Res 181(2):e47–e55. doi:10.1016/j.jss.2012.07.030. Epub 2012

  7. Luyt CE, Landivier A, Leprince P, Bernard M, Pavie A, Chastre J, Combes A (2012) Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock. J Crit Care 27(5):524.e7–e14

    Article  CAS  Google Scholar 

  8. Chen JS, Ko WJ, Yu HY, Lai LP, Huang SC, Chi NH, Tsai CH, Wang SS, Lin FY, Chen YS (2006) Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 34(4):950–957

    Article  PubMed  Google Scholar 

  9. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS (2002) Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 73(2):538–545

    Article  PubMed  Google Scholar 

  10. Luo XJ, Wang W, Hu SS, Sun HS, Gao HW, Long C, Song YH, Xu JP (2009) Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg 9(2):296–300

    Article  PubMed  Google Scholar 

  11. Haneya A, Philipp A, Diez C, Schopka S, Bein T, Zimmermann M, Lubnow M, Luchner A, Agha A, Hilker M, Hirt S, Schmid C, Müller T (2012) A 5-year experience with cardiopulmonary resuscitation using extracorporeal life support in non-postcardiotomy patients with cardiac arrest. Resuscitation 83(11):1331–1337

    Article  PubMed  Google Scholar 

  12. Platts DG, Sedgwick JF, Burstow DJ, Mullany DV, Fraser JF (2012) The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation. J Am Soc Echocardiogr 25(2):131–141

    Google Scholar 

  13. Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A, Diebold B, Chastre J, Combes A (2011) Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med 37(11):1738–1745

    Article  PubMed  Google Scholar 

  14. Chang WW, Tsai FC, Tsai TY, Chang CH, Jenq CC, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC (2012) Predictors of mortality in patients successfully weaned from extracorporeal membrane oxygenation. PLoS One 7(8):e42687

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Formica F, Avalli L, Colagrande L, Ferro O, Greco G, Maggioni E, Paolini G (2010) Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 10(5):721–726

    Article  PubMed  Google Scholar 

  16. Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, Mohr FW (2010) Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 139(2):302–311, 311.e1

    Article  PubMed  Google Scholar 

  17. Zhang R, Kofidis T, Kamiya H, Shrestha M, Tessmann R, Haverich A, Klima U (2006) Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg 30(4):617–620

    Article  CAS  PubMed  Google Scholar 

  18. Doll N, Kiaii B, Borger M, Bucerius J, Krämer K, Schmitt DV, Walther T, Mohr FW (2004) Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 77(1):151–157; discussion 157

    Article  PubMed  Google Scholar 

  19. Givertz MM, Andreou C, Conrad CH, Colucci WS (2007) Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships. Circulation 115(10):1218–1224

    CAS  PubMed  Google Scholar 

  20. Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenpera M (1998) Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19(4):660–668

    Article  CAS  PubMed  Google Scholar 

  21. Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ (2000) Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 36(6):1903–1912

    Article  CAS  PubMed  Google Scholar 

  22. Parissis JT, Karavidas A, Bistola V, Paraskevaidis IA, Farmakis D, Korres D, Filippatos G, Matsakas E, Kremastinos DT (2008) Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis 197(1):278–282

    Article  CAS  PubMed  Google Scholar 

  23. Marzorati C, Erba L, Cortinovis B, Pagan de Paganis C, Avalli L, Sangalli F (2013) Levosimendan infusion during ECMO weaning: effect on endothelial function and haemodynamics. Appl Cardiopulm Pathophysiol 7:170–171

    Google Scholar 

  24. Pecha S, Yildirim Y, Reichenspurner H, Deuse T (2012) Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure. Interact Cardiovasc Thorac Surg 15(5):922–923

    Article  PubMed Central  PubMed  Google Scholar 

  25. Milliez P, Thomas O, Haggui A, Schurando P, Squara P, Cohen-Solal A, Mebazaa A, Leenhardt A (2008) Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term study. Eur J Heart Fail 10(3):291–297

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna Coppo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Coppo, A., Galbiati, L., Redaelli, G. (2014). Weaning from Extracorporeal Circulatory Support. In: Sangalli, F., Patroniti, N., Pesenti, A. (eds) ECMO-Extracorporeal Life Support in Adults. Springer, Milano. https://doi.org/10.1007/978-88-470-5427-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5427-1_18

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5426-4

  • Online ISBN: 978-88-470-5427-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics